FDA Approves Two Cell-Based SCD Gene Therapies

February 2024The U.S. Food and Drug Administration (FDA) approved exagamglogene autotemcel (exa-cel) and lovotibeglogene autotemcel (lovo-cel) for the treatment of sickle cell disease (SCD) in patient

Updated on: February 18,2024

FDA Approves Two Cell-Based SCD Gene Therapies

February 2024The U.S. Food and Drug Administration (FDA) approved exagamglogene autotemcel (exa-cel) and lovotibeglogene autotemcel (lovo-cel) for the treatment of sickle cell disease (SCD) in patient

Updated on:February 18,2024

Travel time for breast cancer screening remains long for many women in the US, new study shows

by American Cancer SocietyA new study led by researchers at the American Cancer Society shows travel time to the nearest mammography facility is long for a considerable proportion of women in the

Updated on: February 20,2024

Travel time for breast cancer screening remains long for many women in the US, new study shows

by American Cancer SocietyA new study led by researchers at the American Cancer Society shows travel time to the nearest mammography facility is long for a considerable proportion of women in the

Updated on:February 20,2024

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

by University of SouthamptonMammograms showing a normal breast (left) and a cancerous breast (right). Credit: Wikipedia.A new study led by scientists at the University of Southampton has found th

Updated on: March 01,2024

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

by University of SouthamptonMammograms showing a normal breast (left) and a cancerous breast (right). Credit: Wikipedia.A new study led by scientists at the University of Southampton has found th

Updated on:March 01,2024

Editorial: Genotype matters—tailored screening for germline CHEK2 variants

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA recent editorial was published inOncotarget, titled "Genotype matters: Personalized screening recommendations for germline CHEK2 var

Updated on: September 07,2024

Editorial: Genotype matters—tailored screening for germline CHEK2 variants

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA recent editorial was published inOncotarget, titled "Genotype matters: Personalized screening recommendations for germline CHEK2 var

Updated on:September 07,2024

Five things to do in your 20s and 30s to reduce your risk of preventable cancer

by Sarah Allinson,The ConversationCredit: AI-generated imageMost of us don't think about cancer when we're in our 20s and 30s. But recent research has shown that people born after 1990 a

Updated on: February 23,2024

Five things to do in your 20s and 30s to reduce your risk of preventable cancer

by Sarah Allinson,The ConversationCredit: AI-generated imageMost of us don't think about cancer when we're in our 20s and 30s. But recent research has shown that people born after 1990 a

Updated on:February 23,2024

New study explores challenges and opportunities for cancer research

by Richard Harth,Arizona State UniversityA recent review by Carlo Maley, a researcher at Arizona State University, and Lucie Laplane from the University of Paris Pantheon-Sorbonne critiques the

Updated on: September 25,2024

New study explores challenges and opportunities for cancer research

by Richard Harth,Arizona State UniversityA recent review by Carlo Maley, a researcher at Arizona State University, and Lucie Laplane from the University of Paris Pantheon-Sorbonne critiques the

Updated on:September 25,2024

Researchers gain new insights into chromosome shortening and identify new potential cancer drug targets

by Institute of Cancer ResearchALT-reliant cells, with telomeres being marked by the green dots. Credit: Cancer and Genome Stability Team at the ICRA new study has provided insights into an impor

Updated on: January 28,2024

Researchers gain new insights into chromosome shortening and identify new potential cancer drug targets

by Institute of Cancer ResearchALT-reliant cells, with telomeres being marked by the green dots. Credit: Cancer and Genome Stability Team at the ICRA new study has provided insights into an impor

Updated on:January 28,2024

Immune cell discovery offers new potential for cancer immunotherapy

byEmory UniversityProposed models of T cell differentiation states in TDLNs. Credit:Nature(2024). DOI: 10.1038/s41586-024-08076-7Researchers at Winship Cancer Institute of Emory Univ

Updated on: November 09,2024

Immune cell discovery offers new potential for cancer immunotherapy

byEmory UniversityProposed models of T cell differentiation states in TDLNs. Credit:Nature(2024). DOI: 10.1038/s41586-024-08076-7Researchers at Winship Cancer Institute of Emory Univ

Updated on:November 09,2024

Quality of treatment for lung cancer varies widely across US

byWashington University in St. LouisA new study by researchers at Washington University School of Medicine in St. Louis found that the quality of care for lung cancer in the U.S. varies widely.

Updated on: December 28,2023

Quality of treatment for lung cancer varies widely across US

byWashington University in St. LouisA new study by researchers at Washington University School of Medicine in St. Louis found that the quality of care for lung cancer in the U.S. varies widely.

Updated on:December 28,2023

Study discovers that tumor mutation burden predicts survival outcome

by Tom Wilemon,Vanderbilt University Medical CenterCredit: Pixabay/CC0 Public DomainThe expected course of a patient's cancer prognosis has traditionally been judged by its type, stage and m

Updated on: January 28,2024

Study discovers that tumor mutation burden predicts survival outcome

by Tom Wilemon,Vanderbilt University Medical CenterCredit: Pixabay/CC0 Public DomainThe expected course of a patient's cancer prognosis has traditionally been judged by its type, stage and m

Updated on:January 28,2024

Prolonging the survival of patients with gastric cancer

by Anne Grimm,Leipzig UniversityCredit: Unsplash/CC0 Public DomainGastric cancer is the fifth most commonly diagnosed malignancy worldwide. It ranks a sad third in cancer-related causes of death

Updated on: January 16,2024

Prolonging the survival of patients with gastric cancer

by Anne Grimm,Leipzig UniversityCredit: Unsplash/CC0 Public DomainGastric cancer is the fifth most commonly diagnosed malignancy worldwide. It ranks a sad third in cancer-related causes of death

Updated on:January 16,2024

Fighting liver cancer takes big financial toll: Study

by Cara MurezOut-of-pocket costs can leave Medicare patients with the most common type of liver cancer in financial distress.While Medicare payments in the first year after diagnosis withhepatoc

Updated on: January 16,2024

Fighting liver cancer takes big financial toll: Study

by Cara MurezOut-of-pocket costs can leave Medicare patients with the most common type of liver cancer in financial distress.While Medicare payments in the first year after diagnosis withhepatoc

Updated on:January 16,2024